Evidence map›Paper›PMID 18635169›Full record

SynthesisFertility and sterility2009

Abnormal uterine bleeding: a review of patient-based outcome measures.

Kristen A Matteson, Lori A Boardman, Malcolm G Munro, Melissa A Clark

Registry-linked trialOpen access · bronzeAbstract readSystematic Review
In one paragraph

Synthesis in Fertility and sterility, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01266759 (Combined Contraceptive Vaginal Ring or Norethisterone for Treatment of Idiopathic Menorrhagia), which is not on this map. Cited by 23 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 4 pooled it
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01266759 nacompletednot on this map

Combined Contraceptive Vaginal Ring or Norethisterone for Treatment of Idiopathic Menorrhagia

TypeinterventionalSponsorMansoura UniversityRan2008 to 2010Enrolled95ConditionsMenorrhagiaArmsNuvaRing, Norethisterone Acetate tablets - 5mg
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 4 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Usual medical treatments or levonorgestrel-IUS for women with heavy menstrual bleeding: long-term randomised pragmatic trial in primary care.The British journal of general practice : the journal of the Royal College of General Practitioners · 2016
    Trial
  6. Trial
  7. Article
  8. Article
  9. Review
  10. Review
  11. Observational
  12. Interventions to improve access to care for abnormal uterine bleeding: A systematic scoping review.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2023
    Article
  13. Article
  14. Menstruation: science and society.American journal of obstetrics and gynecology · 2020
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Outcome measures for heavy menstrual bleeding.Women's health (London, England) · 2016
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kristen A MattesonWomen and Infants Hospital, Warren Alpert School of Medicine, Brown University, 101 Dudley Street, Providence, RI 02905, USA. KMatteson@wihri.org
Lori A Boardman
Malcolm G Munro
Melissa A Clark
Brown University · USKaiser Permanente · US

Funding

Brown/WIH Women's Reproductive Health Research Career Development ProgramK12HD050108 · NICHD · WOMEN AND INFANTS HOSPITAL-RHODE ISLAND · PI HAMPTON, BRITTANY STAR · 2005 to 2019
$4.1M
NICHD NIH HHS K12 HD050108NICHD NIH HHS K12-HD 050108-02NICHD NIH HHS L30 HD048287
6 · The paper itself

Abstract

objectiveTo summarize and evaluate the patient-based outcome measures (PBOMs) that have been used to study women with abnormal uterine bleeding (AUB).

designSystematic review.

settingOriginal articles that used at least one PBOM and were conducted within a population of women with AUB. PATIENT(S): Women with AUB. INTERVENTION(S): The titles, abstracts, and studies were systematically reviewed for eligibility. The PBOMs used in eligible studies were summarized. Essential psychometric properties were identified, and a list of criteria for each property was generated. MAIN OUTCOME MEASURE(S): "Quality" of individual PBOMs as determined using the listed criteria for psychometric properties. RESULT(S): Nine hundred eighty-three studies referenced AUB and patient-reported outcomes. Of these, 80 studies met the eligibility criteria. Fifty different instruments were used to evaluate amount of bleeding, bleeding-related symptoms, or menstrual bleeding-specific quality of life. The quality of each of these instruments was evaluated on eight psychometric properties. The majority of instruments had no documentation of reliability, precision, or feasibility. There was no satisfactory evidence that any one instrument completely addressed all eight psychometric properties. CONCLUSION(S): Studies of women with AUB are increasingly using PBOMs. Many different PBOMs were used; however, no single instrument completely addressed eight important measurement properties.

Indexed as

FemaleHumansMenstruation DisturbancesPatient SelectionQuality of LifeReproducibility of ResultsSurveys and QuestionnairesTreatment OutcomeUterine Hemorrhage

Identifiers

PMID18635169
PMCPMC2746391
OpenAlexW2008015311

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.